Estrogen Treatment in Acromegalic Women
Phase 2
- Conditions
- Acromegaly
- Registration Number
- NCT00315107
- Lead Sponsor
- Université de Montréal
- Brief Summary
Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.
- Detailed Description
This will be a canadian multicenter study with a randomized, double-blind, placebo-controlled design, to assess the efficacy and safety of adjuvant alesse in female acromegalic patients with suboptimal response to sandostatin LAR treatment.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
- Women 18 years and older treated with somatostatin analogs
- Active acromegaly
Exclusion Criteria
- Cardiovascular or cerebrovascular disease
- Thrombophlebitis or thromboembolism
- Breast cancer
- Non-controlled arterial hypertension
- Smoking
- Pregnancy or lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHUM - Notre-Dame Hospital
🇨🇦Montreal, Quebec, Canada